03.12.2013 18:00:00
|
Intrasense Signs a Global OEM Agreement with Cerner
Regulatory News:
INTRASENSE (Paris:ALINS), an international leader in multimodal medical imaging software, announces the signature of a global OEM agreement with Cerner, one of the largest health care IT providers.
The agreement includes the integration of the Myrian® medical imaging software solution into the Cerner PACS offering (Picture Archiving and Communication System). Myrian® is a vendor-neutral solution for interpreting, analyzing and sharing medical images, notably in the field of oncology.
Cerner® solutions are licensed by approximately 10,000 facilities around the world, including more than 2,700 hospitals. Through this agreement, Cerner will distribute the Myrian® technology as part of their product portfolio with a rollout on a global basis.
"Intrasense offers a proven product that has already convinced a great number of our clients. This expanded offering through Myrian® enlarges our portfolio and offers a robust visualization solution to our existing and future clients” said Andre Neu, Director of European Imaging with Cerner.
Patrick Mayette, Intrasense CEO, adds: "We are proud to have such a collaboration with one of the major actors on the market. This OEM agreement is highly important for both Cerner and Intrasense and we will cooperate to build an ever-stronger value proposition through the smart combination of our products. Users will benefit from the added capabilities this partnership will provide to their operations."
About Intrasense:
Intrasense
designs, develops and markets Myrian®, a unique, vendor-neutral software
suite for the visualization and advanced processing of multimodal
medical images such as MRI, CT scans, PET, X-rays, and more. Developed
with leading academic and scientific partners, Myrian® combines and uses
all of the various medical images to extract information vital to the
patient's care, to evaluate treatment efficiency and to assess drug
candidates in oncology and other pathologies. With more than 700 client
sites around the world, Myrian® has been certified as a "medical device"
in over 40 countries including the United States (FDA), Europe (CE) and
Asia. Intrasense SA is listed on the Alternext (FR0011179886 - ALINS).
For
more about Intrasense, please visit www.intrasense.fr
and follow us on LinkedIn.
About Cerner:
Cerner is
contributing to the systemic change of health and care delivery. For
more than 30 years Cerner has been executing its vision to make health
care safer and more efficient. We started with the foundation of
digitizing paper processes and now offer the most comprehensive array of
information software, professional services, medical device integration,
remote hosting and employer health and wellness services. Cerner systems
are used by everyone from individual consumers, to single-doctor
practices, hospitals, employers and entire countries. Taking what we've
learned over more than three decades, Cerner is building on the
knowledge that is in the system to support evidence-based clinical
decisions, prevent medical errors and empower patients in their care.
Cerner®
solutions are licensed by approximately 10,000 facilities around the
world, including more than 2,700 hospitals; 4,150 physician practices;
45,000 physicians; 550 ambulatory facilities, such as laboratories,
ambulatory centers, behavioral health centers, cardiac facilities,
radiology clinics and surgery centers; 800 home health facilities; 45
employer sites and 1,750 retail pharmacies.
For more information
about Cerner, please visit www.cerner.com,
Twitter,
Facebook
and
YouTube.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu INTRASENSEmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu INTRASENSEmehr Analysen
Aktien in diesem Artikel
INTRASENSE | 0,43 | -3,15% |
|